Pharma

Your Article Summary

See Latest Articles

Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Cell Therapeutics, 06/22/09

Cell Therapeutics, Inc. announced the final results of its separate concurrent fixed price exchange offers for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes. The Exchange Offers expired, New York City time, on Tuesday, June 2009.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

Explaining Innovation
PharmExec, 10/16/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

See All of Financial Reports